About this Webinar: This overview draws on the best scientific background providing an overview of the best anti-cancer diet. Busting dietary myths, the benefits of time-restricted eating and practical shopping and meal preparation advice will be highlighted. Join this essential presentation to improve your body’s capacity to recover from cancer.
About the Presenter: Dr. Rob Rutledge is a Radiation Oncologist in Halifax, Nova Scotia, specializing in breast, prostate and pediatric cancers, and is an Associate Professor in the Faculty of Medicine at Dalhousie University. His passion is empowering people affected by cancer, and has delivered hundreds of public talks and webinars, along with over 60 retreats and day-long seminars to thousands of cancer survivors. Rob has received a Cancer Care Nova Scotia Award for Excellence in Patient Care, and Doctors Nova Scotia presented him with a Health Promotion Award in recognition of his contribution to physician health and health promotion in cancer patients. Rob co-leads CancerPEP, a comprehensive six-month daily patient empowerment program starting in November. Visit CancerPEP.org to learn more.
About this Webinar: What is a PET scan, and why is it so crucial in detecting and understanding cancer? Join us for this informative webinar from Dr. Christopher O’Brien, a physician and leader in the nuclear medicine community, where he’ll break down the basics of PET scans in simple, clear terms. Learn how these advanced imaging tools can detect a variety of cancers, guide treatment decisions, and empower you to advocate confidently with your healthcare team. Whether you’re a patient, caregiver, or loved one, this session will leave you informed and ready to take charge of your care.
About this Presenter: Dr Christopher O’ Brien is a leader in the nuclear medicine community. He was Chair of the Ontario Medical Association Section on Nuclear Medicine for over 10 years. He is also past president of the Canadian Association of Nuclear Medicine as well as the Ontario Association of Nuclear Medicine. In addition, he was a Board member of the Royal College of Physician and Surgeons for eight years. Currently Dr. O’Brien is the Medical Director and Chief of Service for Nuclear Medicine at Brantford General Hospital and Pembroke Regional Hospital as well as coordinating and leading the Division of Nuclear Medicine at Stratford General Hospital. His focus has been ensuring a high-quality nuclear medicine program for the patients in the communities he serves for over 30 years.
About this Webinar: This presentation will cover the ongoing journey to secure access to pemigatinib (Pemazyre®) for cholangiocarcinoma patients in Canada. This talk highlights the power of collaboration—showcasing how patients, caregivers, advocacy groups, researchers, scientists, physicians, and industry partners can come together to drive meaningful change.
About the Presenter: Leonard Angka has a Masters in Pharmaceutical Science from the University of Waterloo and received his PhD in Cancer Immunology under the supervision of Dr. Rebecca Auer at the Ottawa Hospital Research Institute in 2021. He coordinated the successful submission of the 2023 Canadian Cancer Society Breakthrough Team Grant application which would ultimately lead to the creation of the Canadian Cholangiocarcinoma Collaborative (C3). Leonard is now the Project Manager for the C3 Program and helps with launching the various C3 initiatives.
View the Video: HERE.
View the Slides: HERE.
About this Webinar: In this webinar, we’ll summarize the findings of a 20-minute online study conducted by Leger among caregivers of cancer patients. We summarized the results of 1,000 current or past 5-year caregivers to cancer patients about their experience with caregiving including support provided to cancer patients, challenges experienced, support sought, and other unmet needs related to caregiving. CCSN aims to use this information to develop better support systems and resources for cancer caregivers.
About this Presenter: Colette Faust is a Research Director at Leger and has 12 years of market research experience, spending the last 5 years in the Healthcare industry. As a member of Leger Healthcare, Colette has worked on both quantitative and qualitative healthcare research among healthcare professionals, patients, and the general population across a variety of topics including oncology.
View the Video: HERE.
View the Slides: HERE
About the Webinar: It’s called the butterfly effect — a theory that the simple brush of a butterfly’s wing can set off a ripple effect, only to become a tsunami that crashes on a distant shore.
But is it really possible for one person — one woman — to make a change that echoes around Earth?
Diagnosed with breast cancer in March of 2022, Ellyn’s experience isn’t extraordinary. One in eight women will experience a breast cancer diagnosis in their lifetime.
However, what is extraordinary is what happened after that diagnosis. Rather than lean into shame, Ellyn chose to own her story openly to help other women and their families on this journey.
Through her best selling book Flat Please Hold the Shame, her Instagram account @flatplease, and AskEllyn.ai, the world’s first lifestyle brand and AI chat, Ellyn’s goal of helping others and vision for “conversational care” is now being realized on a global level, in every language, and at an unprecedented scale. Even better, Ellyn’s story is now inspiring changemakers from across the world to embrace AI for social impact.
About the Presenter: Ellyn Winters-Robinson is a breast cancer survivor, in-demand speaker, women’s health advocate, professional communicator and a globally recognized health rebel. She is the author of the best-selling book “Flat Please Hold the Shame,” a girlfriend’s companion guide for those on the breast cancer journey and the real woman behind the global AI phenomena, AskEllyn.ai, the world’s first conversational AI companion for those on the breast cancer journey. Ellyn’s story and AskEllyn.ai have been featured in People Magazine, Chatelaine Magazine, the Globe and Mail, CTV National News and Your Morning, and Fast Company.
View the Video: HERE.
About this Webinar: Human Papillomavirus (HPV) causes cervical cancer and is linked to eight other types of cancer (vulvar, vaginal, penile, anal, throat, tongue, tonsil, and vocal cords), yet many of these cancers can be prevented. This webinar will explain how HPV affects health, highlight Canada’s HPV prevention programs including free school-based initiatives also available to immunocompromised individuals and discuss the importance of cervical screening. Participants will gain clear information and practical resources to empower themselves and protect their loved ones.
About this Presenter: Teresa Norris is the Founder and President of HPV Global Action and the newly elected President of the Quebec Cancer Coalition. With over 20 years of experience in cancer prevention and sexual and reproductive health education that has reached to date more than 100,000 students across Canada. She has developed evidence-based HPV and cancer prevention programs and is shaping health policies both nationally and internationally. She also leads the INTEGRATION Project in Eswatini, a global collaboration with the National Institute of Health (NIH), National Cancer Institute (NCI) , and World Health Organization (WHO) dedicated to addressing the burden of cervical cancer, HIV, and neglected tropical diseases. Teresa’s work is guided by a deep commitment to improving health outcomes, cancer patient advocacy, and equitable access to care.
View the Video: Here.
About this Webinar: Interventions are considered complex when a number of factors associated with their use contribute to their effectiveness. An emerging complex intervention is the use of T-cell redirecting therapy. These therapies change the behaviour of a patient’s T-cells to modify (usually amplify) an immune response.
There are currently two types of T-cell redirecting therapies currently funded in Canada: chimeric antigen receptor T-cell (CAR-T) therapies , and; bispecific T-cell engagers (BiTEs). These therapies have created the need for interdisciplinary teams due to heightened requirements for care coordination and toxicity management. Delivering these therapies creates several challenges for healthcare systems ranging from focused educational strategies to improved protocols and more sophisticated resource planning.
The use of T-cell redirecting therapy is likely to grow in coming years due to better experience with the interventions, introduction in earlier lines of therapy, reduced costs of delivery, and expansion into other therapeutic areas including outside of cancer. Health systems may create unnecessary delays for patient access if they are not prepared to quickly change approaches to care delivery.
Don Husereau will describe alternative feasible approaches to care delivery, or initiatives that may support the safe delivery and access to care of complex therapies in the Canadian health system setting, including the coming wave of T-cell redirecting therapies.
About the Presenter: DON HUSEREAU is an Adjunct Professor of Medicine at The University of Ottawa. He does freelance health care research, and works with private and public sector life sciences organizations to help them understand the value of health technology and its implications for health and innovation policy.
Watch the Video: HERE.